Therefore, novel biomarkers such as PCA3, TMPRSS2-ERG and some microRNAs [19] etc. have been assessed for their diagnostic and prognostic role in PCa, especially the detection of these biomarker in the body fluid such as blood, urine or seminal fluid. This evidence concerns the gene ERG and posterior cortical atrophy.